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Accepted 24 September 2013Focal cortical dysplasia type IIb (FCDIIb) is a malformation of
cortical development characterized by the presence of balloon cells
and dysmorphic neurons and often associated with focal epilepsy,1
but not with progressive neurological deﬁcits. We report a patient
with slowly progressive aphasia as the predominant symptom of
FCDIIb with no evidence of electrographic seizures on scalp EEG.
Eight years after initial presentation, subacute worsening of her
language prompted repeat MRI which revealed changes suggestive
of a neoplasm. Biopsy instead revealed FCDIIb. This case
exempliﬁes a challenging differential diagnosis and an unusual
presentation of FCDIIb.
1. Case report
A 32 year old right-handed woman presented with two
convulsive seizures in 2004. EEG showed left temporal discharges;
brain MRI was unrevealing. Neurological exam was unremarkable
despite complaints of word ﬁnding difﬁculties. Clinically apparent
seizures were controlled with antiepileptic drug (AED).
In 2008, she reported deterioration in word-ﬁnding and
understanding information over the telephone. Exam revealed
mild impairment of repetition. Repeat MRI remained unremark-
able; EEG showed increased left temporal discharges. Magne-§ No statistical analysis was involved in this study.
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distribution. Word ﬁnding difﬁculties were considered a possible
ictal phenomenon and were treated with multiple AEDs without
improvement. CSF immuno-electropheresis, oligoclonal bands,
lactate and pyruvate were unremarkable. Work-up for autoim-
mune encephalitides (Hu, Yo, Ma1, Ma2, voltage gated potassium
and calcium channels, thyroglobulin, TPO, gluR3, GAD antibodies)
was negative.
Dysphasic symptoms slowly progressed despite high-dose
methyl-prednisolone, adjustment of AEDs, speech therapy and
modiﬁed Atkins diet. Multiple EEGs showed left parietal and
centro-temporal periodic discharges, but no deﬁnite ictal activity
apparent on scalp EEG. In 2010, intermittent right facial jerks
developed and correlated with generalized decrement and
dissipation of the left temporal discharges on video-EEG. Brain
PET showed hypo-metabolism in the left frontal, parietal and
temporal lobes and hyper-metabolism in the left temporal caudate
head. Multiple high-resolution MRIs remained unremarkable (see
Fig. 1A for a representative example).
In 2012, she developed subacute deterioration of receptive
language and increased facial jerks. Brain MRI revealed a ‘‘new
focal mass lesion involving the left temporal and parietal region
concerning for a low-grade glial neoplasm’’. EEG showed left
central discharges, but no overt seizures. Repeat PET revealed
increased uptake in the left lateral temporal lobe. MR spectroscopy
showed elevated choline to creatine and decrease in NAA,
consistent with demyelinating disease or low-grade glioma.
Neuro-oncology consultant recommended brain biopsy.
Open biopsy was performed in the Advanced Multimodality
Image Guided Operating (AMIGO) suite. Interictal discharges, but
not ictal activity were recorded with intra-operative electrocorti-
cography. Biopsy specimens from 3 cortical areas of maximal
overlapping abnormality from MRI (Fig. 1B), PET (Fig. 1C), and
electrocorticogram were obtained. Motor and language areas
identiﬁed on pre-operative fMRI and intra-operative motor
mapping were spared.
Pathological evaluation showed FCDIIb from all sampled areas,
characterized by dyslamination (Fig. 2A), conﬁrmed by NeuN-
immunostain (not shown); pale, glassy, balloon-like cells (Fig. 2B);vier Ltd. All rights reserved.
Fig. 1. Imaging features of the lesion before and after biopsy. (A) Axial FLAIR image 4 years before diagnosis of FCDIIb was established shows no evidence of cortical dysplasia,
heterotopia, mass lesion or vascular lesion. (B) Axial FLAIR image shows increase in signal at the left posterior temporal parietal lobe involving both gray and white matter
through more subcortical white matter. (C) Single axial PET image at the same level reveals increased uptake at the corresponding area of MR signal abnormality (white
arrows), signifying increased metabolic activity. (D) One month after brain biopsy, axial FLAIR image demonstrates interval decrease in signal abnormality at the prior site
with associated post-op changes.
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(Fig. 2C). There was also extensive GFAP-positive reactive gliosis
and CD163-positive perivascular microglia (not shown); there
were no lymphocytic inﬁltrates. There was very low suspicion for
neoplasia on histology, given the lack of glial cell atypia. Moreover,
a MIB-1 immunostain showed only rare positive cells, and IDH1
(R132H mutation) immunostain was negative (not shown).
Her symptoms and MRI abnormalities improved post-opera-
tively (Fig. 1D) as a possible result of AED adjustments and the
effect of anesthesia. This improvement suggests that the MRI
abnormalities were likely related to ongoing seizure activity.4
Epilepsy surgery was considered but not pursued because the
patient and family were no longer interested in a resection due to
the presence of the lesion in eloquent cortex.
2. Discussion
This case demonstrates an atypical presentation and clinical
course of FCDIIb which is characterized by localized regions ofmalformed cerebral cortex1 and frequently associated with drug
resistant focal epilepsy in both children and adults (ages <1–60
years).2 Neurological deﬁcits are not usually present interictally
except in early onset or severe cases or if the malformation is
related to known early-onset brain injury whereby cognitive
deﬁcits or delay in psychomotor development are also seen.3
Alternative diagnoses were entertained but considered
unlikely or ruled out during the course of the presentation.
These included autoimmune encephalitis, adult onset Landau-
Kleffner syndrome (but no nocturnal accentuation of
discharges was present) and non-ﬂuent/agrammatic variant of
primary progressive aphasia (can appear in the third decade).
Malignant transformation of a slow growing tumor causing
progressive neurological deﬁcits and seizures became the
main suspected diagnosis after late MRI abnormalities
appeared.
Our case demonstrates an unusual presentation of FCD in
several regards. In addition to the relatively well-controlled overt
seizures, slowly progressing aphasia dominated the clinical
Fig. 2. Pathological evaluation of the biopsy specimen. (A) Focal cortical dysplasia, characterized by cortical dyslamination seen at low power (original magniﬁcation 100).
(B) Enlarged neurons and occasional glassy, eosinophilic ‘‘balloon cells’’ (arrow, original magniﬁcation 400). (C) Dysplastic neurons highlighted by neuroﬁlament
immunostain (SMI-31 monoclonal antibody, standard methods).
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activity and were not useful in following the clinical course as there
was likely an ongoing ictus in deeper areas inaccessible by surface
EEG. Most importantly, our patient had unremarkable structural
imaging for over 8 years followed by sudden appearance of marked
signal changes on MRI suggesting malignancy and necessitating
brain biopsy. However, MRI abnormalities were likely related to
increased seizures,4 even though no major change in surface EEG
was noted. Awareness of this presentation of FCDIIb is of major
clinical importance for timely diagnosis and treatment of such
patients.
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